These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17325908)

  • 1. Durable remission after the administration of rituximab for EBV-negative, diffuse large B-cell lymphoma following autologous peripheral blood stem cell transplantation for angioimmunoblastic T-cell lymphoma.
    Shinohara A; Asai T; Izutsu K; Ota Y; Takeuchi K; Hangaishi A; Kanda Y; Chiba S; Motokura T; Kurokawa M
    Leuk Lymphoma; 2007 Feb; 48(2):418-20. PubMed ID: 17325908
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful rituximab treatment of an EBV-related lymphoproliferative disease arising after autologous transplantation for angioimmunoblastic T-cell lymphoma.
    Park S; Noguera ME; Brière J; Feuillard J; Cayuela JM; Sigaux F; Brice P
    Hematol J; 2002; 3(6):317-20. PubMed ID: 12522456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue.
    Heath JA; Broxson EH; Dole MG; Filippa DA; George D; Lyden D; Dunkel IJ
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):160-3. PubMed ID: 11998794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma.
    Awaya N; Adachi A; Mori T; Kamata H; Nakahara J; Yokoyama K; Yamada T; Kizaki M; Sakamoto M; Ikeda Y; Okamoto S
    Leuk Res; 2006 Aug; 30(8):1059-62. PubMed ID: 16330097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Epstein-Barr virus-associated B cell lymphoma after intensive treatment of patients with angioimmunoblastic lymphadenopathy with dysproteinemia.
    Matsue K; Itoh M; Tsukuda K; Kokubo T; Hirose Y
    Int J Hematol; 1998 Apr; 67(3):319-29. PubMed ID: 9650454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal central nervous system lesions emerging during anti-CD20 monoclonal antibody therapy (Rituximab) for a post transplantation Epstein Barr virus-linked lymphoma.
    Sirvent-Von Bueltzingsloewen A; Sirvent N; Morand P; Cassuto JP
    Med Pediatr Oncol; 2003 Jun; 40(6):408-9. PubMed ID: 12692818
    [No Abstract]   [Full Text] [Related]  

  • 7. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma.
    Skugor ND; Perić Z; Vrhovac R; Radić-Kristo D; Kardum-Skelin I; Jaksić B
    Coll Antropol; 2010 Mar; 34(1):241-5. PubMed ID: 20432757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary Epstein-Barr virus associated lymphoproliferative disorder developing in a patient with angioimmunoblastic T cell lymphoma on vorinostat.
    Smeltzer JP; Viswanatha DS; Habermann TM; Patnaik MM
    Am J Hematol; 2012 Sep; 87(9):927-8. PubMed ID: 22718468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of primary cardiac lymphoma by rituximab-CHOP and high-dose chemotherapy with autologous peripheral blood stem cell transplantation.
    Nonami A; Takenaka K; Kamezaki K; Miyamoto T; Harada N; Nagafuji K; Teshima T; Harada M
    Int J Hematol; 2007 Apr; 85(3):264-6. PubMed ID: 17483065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab.
    Yamagata M; Murohisa T; Tsuchida K; Okamoto Y; Tsunoda S; Nakamura M; Kusano K; Majima Y; Kuniyoshi T; Iijima M; Sugaya H; Hiraishi H
    Leuk Lymphoma; 2007 Feb; 48(2):431-3. PubMed ID: 17325912
    [No Abstract]   [Full Text] [Related]  

  • 11. Rituximab for bone lymphoma.
    Savage DG; Staron R
    Ann Intern Med; 2001 Jun; 134(12):1156-7. PubMed ID: 11412072
    [No Abstract]   [Full Text] [Related]  

  • 12. Intra-vascular large B-cell lymphoma revealed by a nephrotic syndrome: a one year remission induced by a high frequency CHOP and rituximab.
    Girard T; Nochy D; Montravers F; Der Sahakian G; Fior R; Galanaud P; Boué F
    Leuk Lymphoma; 2004 Aug; 45(8):1703-5. PubMed ID: 15370230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus, B cells, T cells, and a lymphoproliferative disorder.
    Ott G; Ott MM; Müller-Hermelink HK
    Lancet; 1994 Apr; 343(8902):922. PubMed ID: 7908386
    [No Abstract]   [Full Text] [Related]  

  • 14. Rituximab for early-stage diffuse large-B-cell lymphoma.
    Friedberg JW
    Lancet Oncol; 2006 May; 7(5):357-9. PubMed ID: 16648037
    [No Abstract]   [Full Text] [Related]  

  • 15. Peripheral T-cell lymphoma following rituximab therapy for B-cell lymphoma.
    Micallef IN; Kirk A; Norton A; Foran JM; Rohatiner AZ; Lister TA
    Blood; 1999 Apr; 93(7):2427-8. PubMed ID: 10215354
    [No Abstract]   [Full Text] [Related]  

  • 16. Rituximab for BCL-2-positive cancers.
    Boughton B
    Lancet Oncol; 2003 Feb; 4(2):69. PubMed ID: 12573343
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful autologous peripheral blood stem cell transplantation with rituximab administration for pediatric diffuse large B-cell lymphoma.
    Imamura T; Yoshihara T; Morimoto A; Ishida H; Sugimoto T; Imashuku S
    Pediatr Hematol Oncol; 2006; 23(1):19-24. PubMed ID: 16326408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab in the treatment of EBV-positive low grade B-cell lymphoma.
    Diamantopoulos PT; Polonyfi K; Sofotasiou M; Papadopoulou V; Kalala F; Iliakis T; Zervakis K; Tsilimidos G; Kouzis P; Kyrtsonis MC; Vassilakopoulos T; Angelopoulou M; Siakantaris M; Vayopoulos G; Kollia P; Pangalis G; Viniou NA
    Anticancer Res; 2013 Dec; 33(12):5693-8. PubMed ID: 24324119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral T-cell lymphoma complicated by a proliferation of large B cells.
    Higgins JP; van de Rijn M; Jones CD; Zehnder JL; Warnke RA
    Am J Clin Pathol; 2000 Aug; 114(2):236-47. PubMed ID: 10941339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].
    Iguchi T; Miyazawa K; Okabe S; Kawakubo K; Shimamoto T; Kuriyama Y; Ito Y; Kimura Y; Ohyashiki K; Serizawa H; Iwaya K; Mukai K
    Rinsho Ketsueki; 2004 Oct; 45(10):1129-34. PubMed ID: 15553050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.